Wintermute
<Charitable Administrator>
- 2,364
- 673
Claims he loves science and posts a feel good fluff faq from the CDC with zero numbers just feels.
- 2
- 1
Lumi's Batshit Insane Thread
- Thread starter Noodleface
- Start date
-
Guest, it's time once again for the massively important and exciting FoH Asshat Tournament!
Go here and give us your nominations!Who's been the biggest Asshat in the last year? Give us your worst ones!
hodj
Vox Populi Jihadi
- 31,672
- 18,378
See that bolded bit a_skeleton_03?
#dealwithit
Youtube videos aren't peer reviewed citations either.
Notice how you're desperately citing anything you can that doesn't fit the criteria I asked you for?
I noticed.
Its because you got de nada, chuckle fuck.
#dealwithit
Youtube videos aren't peer reviewed citations either.
Notice how you're desperately citing anything you can that doesn't fit the criteria I asked you for?
I noticed.
Its because you got de nada, chuckle fuck.
- 1
hodj
Vox Populi Jihadi
- 31,672
- 18,378
Genetic fallacy
You might as well have just said "Shit, my troll game is up. Good job Hodj".
Same effect, less egg on your face in the process.
- 1
hodj
Vox Populi Jihadi
- 31,672
- 18,378
Fyi a_skeleton_03
How does hepatitis B spread?
Hepatitis B virus spreads through blood or other body fluids that contain small amounts of blood from an infected person. People can spread the virus even when they have no symptoms.
Babies and children can get hepatitis B in the following ways:
How does hepatitis B spread?
Hepatitis B virus spreads through blood or other body fluids that contain small amounts of blood from an infected person. People can spread the virus even when they have no symptoms.
Babies and children can get hepatitis B in the following ways:
- At birth from their infected mother
- Being bitten by an infected person
- By touching open cuts or sores of an infected person
- Through sharing toothbrushes or other personal items used by an infected person
- From food that was chewed (for a baby) by an infected person
- 1
Wintermute
<Charitable Administrator>
- 2,364
- 673
The bolded bit that doesn't have an ounce of science?
The bolded bit that also doesn't disagree with me?
- 2
- 2
hodj
Vox Populi Jihadi
- 31,672
- 18,378
Being admin has destroyed your trollfu.
This post is so bad it gave me hep b and cancer. Despite my vaccinations.
- 1
Wintermute
<Charitable Administrator>
- 2,364
- 673
How so?
They don't back it with even the most basic of numbers like: "It should be done because 1 out of 7,000 babies could get it"
It's because we say so in the FAQ.
They don't disagree with me either. They say before the baby goes home. You, me, and the CDC all think that young babies need the Hep B vaccine. I don't believe they need it in hour 0 before they are fully assessed and monitored. You and the CDC believe that they do.
What do we differ on? The world you are looking for is "schedule".
By the way if a baby contracts Hep B during the childbirth process giving them a vaccine doesn't make them immune after the fact .... It isn't a vaccine if you are giving it after infection .....
- 2
- 2
hodj
Vox Populi Jihadi
- 31,672
- 18,378
How so?
You talk about "Science" like its a fucking fluid that you fill cups with. Retarded.
http://www.immunize.org/catg.d/p4205.pdf
How common is hepatitis B in the United States? About 3,000 to 4,000 cases of acute hepatitis B are reported annually to the Centers for Disease Control and Prevention; however, the number of new infections is estimated to be much higher. Since the introduction of routine vaccination against hepatitis B virus infection, there has been a significant decline in U.S. cases among children and adolescents, the group with the largest increase in hepatitis B vaccination coverage. However, chronic hepatitis B virus infection remains a major problem.
An estimated 800,000 to 1.4 million people are chronically infected with hepatitis B in the United States. Many people chronically infected with hepatitis B virus do not know they are infected. Most cases of chronic hepatitis B virus infection in the United States are found in immigrants or refugees from Asia, Africa, the Pacific Islands, and Eastern Europe. Worldwide, more than 350 million people are chronically infected with hepatitis B virus and more than 1 million of these people die each year from cirrhosis leading to liver failure or liver cancer
Achievements in Public Health: Hepatitis B Vaccination --- United States, 1982--2002
Since 1982, substantial progress has been made toward eliminating HBV transmission in children and reducing the risk for HBV infection in adults. During 1982--2002, an estimated 40 million infants and children and 30 million adults received hepatitis B vaccine. Because of vaccination and changes in risk-reduction behaviors among at-risk populations in response to the HIV/AIDS epidemic, the number of persons infected in the United States declined to an estimated 79,000 in 2001. To eliminate HBV transmission, high vaccine-coverage rates must be sustained among infants, children, and adolescents, and programs to vaccinate adults at high risk for HBV infection must be expanded.
Here's your "ounce of science" refuting your claim that this vaccine is just unnecessary at birth.
Donald has something to say about your claim
You talk about "Science" like its a fucking fluid that you fill cups with. Retarded.
http://www.immunize.org/catg.d/p4205.pdf
How common is hepatitis B in the United States? About 3,000 to 4,000 cases of acute hepatitis B are reported annually to the Centers for Disease Control and Prevention; however, the number of new infections is estimated to be much higher. Since the introduction of routine vaccination against hepatitis B virus infection, there has been a significant decline in U.S. cases among children and adolescents, the group with the largest increase in hepatitis B vaccination coverage. However, chronic hepatitis B virus infection remains a major problem.
An estimated 800,000 to 1.4 million people are chronically infected with hepatitis B in the United States. Many people chronically infected with hepatitis B virus do not know they are infected. Most cases of chronic hepatitis B virus infection in the United States are found in immigrants or refugees from Asia, Africa, the Pacific Islands, and Eastern Europe. Worldwide, more than 350 million people are chronically infected with hepatitis B virus and more than 1 million of these people die each year from cirrhosis leading to liver failure or liver cancer
Achievements in Public Health: Hepatitis B Vaccination --- United States, 1982--2002
Since 1982, substantial progress has been made toward eliminating HBV transmission in children and reducing the risk for HBV infection in adults. During 1982--2002, an estimated 40 million infants and children and 30 million adults received hepatitis B vaccine. Because of vaccination and changes in risk-reduction behaviors among at-risk populations in response to the HIV/AIDS epidemic, the number of persons infected in the United States declined to an estimated 79,000 in 2001. To eliminate HBV transmission, high vaccine-coverage rates must be sustained among infants, children, and adolescents, and programs to vaccinate adults at high risk for HBV infection must be expanded.
Here's your "ounce of science" refuting your claim that this vaccine is just unnecessary at birth.
Donald has something to say about your claim
- 1
hodj
Vox Populi Jihadi
- 31,672
- 18,378
To eliminate HBV transmission, high vaccine-coverage rates must be sustained among infants, children, and adolescents, and programs to vaccinate adults at high risk for HBV infection must be expanded.
So what have we learned today?
That the reason for giving the vaccination is to continue to reduce the number of new infection cases across the board in children, in order to protect the population from Hep B, which causes liver failure and cancer, among a variety of other complications, all of which are worse when you contract the disease as a child.
- 1
hodj
Vox Populi Jihadi
- 31,672
- 18,378
Achievements in Public Health: Hepatitis B Vaccination --- United States, 1982--2002
Some more for you on the history of why the vaccine is given to children
In 1991, recognizing the difficulty of vaccinating high-risk adults and the substantial burden of HBV-related disease acquired from infections in childhood, ACIP recommended a comprehensive strategy to eliminate HBV transmission in the United States (4). The strategy focused on universal childhood vaccination, prevention of perinatal HBV transmission, vaccination of adolescents and adults in high-risk groups, and catch-up vaccinations for susceptible children in high-risk populations. In 1995, ACIP recommended the routine vaccination of all adolescents aged 11--12 years who had not been vaccinated previously (5), and in 1999, ACIP recommended that all unvaccinated children aged <19 years be vaccinated (6). The ACIP vaccination strategies for children and adolescents have been implemented successfully in the United States, and hepatitis B vaccine is now considered part of the routine childhood vaccination schedule. During 1993--2000, the national coverage rate for hepatitis B vaccine among children aged 19--35 months increased from 16% to 90%, and the coverage rate for U.S. adolescents aged 13--15 years increased from near zero to 67%.
Part of the success of these strategies can be attributed to the availability of expanded funding for childhood vaccinations and to laws requiring vaccination of school children. In 1994, Congress enacted Vaccines for Children, a national program to purchase ACIP-recommended vaccines for eligible children aged <19 years. Laws have been enacted in 44 states mandating hepatitis B vaccination for children entering elementary schools and childcare centers and in 34 states requiring vaccination for adolescents in middle school (7).
Substantial declines in the incidence of acute hepatitis B have occurred among highly vaccinated populations, such as young children and health-care workers. During 1986--2000, the rate of acute hepatitis B among children aged 1--9 years declined >80% (Figure). During 1983--1995, the rate of HBV infection in health-care workers declined 95% and is now lower than the rate for the general U.S. population (8).
Since hepatitis B vaccination began in 1982, the prevalence of chronic HBV infection has been reduced substantially among populations whose infection rates previously were high. For example, in 1994, the prevalence of chronic HBV infection among Alaska Natives aged <10 years (i.e., children born after routine vaccination began) was zero, compared with 16% among Alaska Natives aged 11--30 years (9).
Some more for you on the history of why the vaccine is given to children
In 1991, recognizing the difficulty of vaccinating high-risk adults and the substantial burden of HBV-related disease acquired from infections in childhood, ACIP recommended a comprehensive strategy to eliminate HBV transmission in the United States (4). The strategy focused on universal childhood vaccination, prevention of perinatal HBV transmission, vaccination of adolescents and adults in high-risk groups, and catch-up vaccinations for susceptible children in high-risk populations. In 1995, ACIP recommended the routine vaccination of all adolescents aged 11--12 years who had not been vaccinated previously (5), and in 1999, ACIP recommended that all unvaccinated children aged <19 years be vaccinated (6). The ACIP vaccination strategies for children and adolescents have been implemented successfully in the United States, and hepatitis B vaccine is now considered part of the routine childhood vaccination schedule. During 1993--2000, the national coverage rate for hepatitis B vaccine among children aged 19--35 months increased from 16% to 90%, and the coverage rate for U.S. adolescents aged 13--15 years increased from near zero to 67%.
Part of the success of these strategies can be attributed to the availability of expanded funding for childhood vaccinations and to laws requiring vaccination of school children. In 1994, Congress enacted Vaccines for Children, a national program to purchase ACIP-recommended vaccines for eligible children aged <19 years. Laws have been enacted in 44 states mandating hepatitis B vaccination for children entering elementary schools and childcare centers and in 34 states requiring vaccination for adolescents in middle school (7).
Substantial declines in the incidence of acute hepatitis B have occurred among highly vaccinated populations, such as young children and health-care workers. During 1986--2000, the rate of acute hepatitis B among children aged 1--9 years declined >80% (Figure). During 1983--1995, the rate of HBV infection in health-care workers declined 95% and is now lower than the rate for the general U.S. population (8).
Since hepatitis B vaccination began in 1982, the prevalence of chronic HBV infection has been reduced substantially among populations whose infection rates previously were high. For example, in 1994, the prevalence of chronic HBV infection among Alaska Natives aged <10 years (i.e., children born after routine vaccination began) was zero, compared with 16% among Alaska Natives aged 11--30 years (9).
- 1
hodj
Vox Populi Jihadi
- 31,672
- 18,378
Long story short, a_skeleton_03, your position is actually the argument from ignorance fallacy. You can't see why vaccination of children for Heb B at birth is useful or effective to combat overall Hep B transmission in the US, therefore you conclude it is unnecessary.
Your ignorance isn't an argument.
Your ignorance isn't an argument.
- 1
Wintermute
<Charitable Administrator>
- 2,364
- 673
Wintermute
<Charitable Administrator>
- 2,364
- 673
Like your ignorance of the prevalence of at birth Hep B contraction numbers.
- 2
- 1
hodj
Vox Populi Jihadi
- 31,672
- 18,378
Shocking how irrelevant that is, and in fact, the reasoning for that has already been cited.
Not shocking that you've skipped over it or ignored it, since that is inconvenient to your troll game.
Your argument is refuted.
Irrelevant. Whether it is 1 child, or 10 million children, the goal is to reduce the overall infection rate across the board, and infant and childhood vaccination is the most effective path towards that goal, and the preventative nature of immunizing new borns so that they do not contract the disease from an unknowing carrier is the justification for the treatment.
@dealwithit
- 1
hodj
Vox Populi Jihadi
- 31,672
- 18,378
Oh and by the way, the numbers you want are here in this graph
Achievements in Public Health: Hepatitis B Vaccination --- United States, 1982--2002
Which was linked in the above copy paste spam that you aren't reading to realize it.
The graph really speaks for itself. That criss cross in 1994 is pretty impressive.
Achievements in Public Health: Hepatitis B Vaccination --- United States, 1982--2002
Which was linked in the above copy paste spam that you aren't reading to realize it.
The graph really speaks for itself. That criss cross in 1994 is pretty impressive.
Wintermute
<Charitable Administrator>
- 2,364
- 673
So you admit that you don't have any issues with an alternate schedule as long as it saves the life of 1 child or 10 million. Got it.
Thanks for playing.
Thanks for playing.
- 2
- 1
Wintermute
<Charitable Administrator>
- 2,364
- 673
hodj
Vox Populi Jihadi
- 31,672
- 18,378
Nope. But whatever you gotta do to get yourself out of this bad and failed troll job you've tried here so you can sleep better tonight!
- 1
hodj
Vox Populi Jihadi
- 31,672
- 18,378
hodj
Vox Populi Jihadi
- 31,672
- 18,378
Preventing Perinatal HBV Transmission
Since 1982, the control of perinatal infection has been a crucial part of ACIP's evolving HBV vaccination strategy. In 1984, ACIP recommended hepatitis B surface antigen (HBsAg) screening for pregnant women in groups at high risk for acquiring HBV infection and postexposure immunoprophylaxis with hepatitis B vaccine and HBIG for all infants born to HBsAg-positive mothers (10). However, within a few years, studies showed that screening women in high-risk groups failed to identify 35%--65% of HBsAg-positive pregnant women (11,12). Consequently, in 1988, ACIP recommended that all pregnant women be screened routinely for HBsAg (13).
In 1990, the federal government began funding perinatal hepatitis B prevention programs to promote prenatal screening of all pregnant women for HBsAg and tracking of infants born to HBsAg-positive mothers to ensure that the infants receive appropriate postexposure prophylaxis. These programs have been implemented successfully. A survey of birthing hospitals conducted in 2000 in 14 states showed that 96.5% of pregnant women had been screened for HBsAg (CDC, unpublished data, 2000). During 2000, state health departments identified and tracked 10,192 infants born to HBsAg-positive mothers (CDC, unpublished data, 2000). Of these infants, 90% received hepatitis B vaccine and HBIG before hospital discharge. At age 6--8 months, 71% of these infants had completed the 3-dose hepatitis B vaccine series. On the basis of these coverage rates, CDC estimates that perinatal HBV infection in the United States declined 75% during 1987--2000 (CDC, unpublished data, 2000).
Since 1982, the control of perinatal infection has been a crucial part of ACIP's evolving HBV vaccination strategy. In 1984, ACIP recommended hepatitis B surface antigen (HBsAg) screening for pregnant women in groups at high risk for acquiring HBV infection and postexposure immunoprophylaxis with hepatitis B vaccine and HBIG for all infants born to HBsAg-positive mothers (10). However, within a few years, studies showed that screening women in high-risk groups failed to identify 35%--65% of HBsAg-positive pregnant women (11,12). Consequently, in 1988, ACIP recommended that all pregnant women be screened routinely for HBsAg (13).
In 1990, the federal government began funding perinatal hepatitis B prevention programs to promote prenatal screening of all pregnant women for HBsAg and tracking of infants born to HBsAg-positive mothers to ensure that the infants receive appropriate postexposure prophylaxis. These programs have been implemented successfully. A survey of birthing hospitals conducted in 2000 in 14 states showed that 96.5% of pregnant women had been screened for HBsAg (CDC, unpublished data, 2000). During 2000, state health departments identified and tracked 10,192 infants born to HBsAg-positive mothers (CDC, unpublished data, 2000). Of these infants, 90% received hepatitis B vaccine and HBIG before hospital discharge. At age 6--8 months, 71% of these infants had completed the 3-dose hepatitis B vaccine series. On the basis of these coverage rates, CDC estimates that perinatal HBV infection in the United States declined 75% during 1987--2000 (CDC, unpublished data, 2000).
- 1